Progressive Tops Keynova's Q3 2026 Mobile Insurance Scorecard

Image
Progressive Tops Keynova's Q3 2026 Mobile Insurance Scorecard

Wilmington, Del. – October 08, 2026 -- Progressive has claimed first place overall and for mobile web in Keynova Group's Q3 2026 Mobile Insurance Scorecard, while Allstate took the top spot for mobile app experience, according to the semi-annual benchmark of the 12 largest U.S. auto and property insurers.

Carriers push personalized savings tools as premiums climb

One-third of the 12 carriers evaluated have introduced enhanced mobile tools that let existing policyholders identify and apply for new discounts, policy options or deductible changes, moving beyond discount offers limited to new-policy quoting. These guided savings assessments factor in a policyholder's current deductibles, coverages and discounts to generate targeted recommendations.

DoiT Partners With OpenAI to Track AI Spend on AWS

Image
DoiT Partners With OpenAI to Track AI Spend on AWS

Santa Clara, Calif. – October 08, 2026 -- DoiT has partnered with OpenAI to help enterprises move AI workloads from pilot to production on Amazon Web Services while tracing every dollar of spend to the customer, feature or agent that generated it.

Monthly AI spend among DoiT's customer base has surged roughly 100-fold in two years

Across DoiT's more than 4,000 customers, AI expenditure has outpaced the tools available to measure returns, pushing finance and engineering leaders to justify which models, features and customers are driving cost -- and whether each pays off.

DXC Expands Assure Platform, Tops 275 Insurer Customers

LONDON – October 08, 2026 -- DXC Technology (NYSE: DXC) has grown Assure Platform adoption to more than 275 customers as it rolls out new AI-enabled tools and London Market investments aimed at modernizing insurer operations without disrupting legacy systems.

DXC adds 18 Smart App customers in one year, reaching 450 insurers

Since launching Assure Smart Apps a year ago, DXC has signed 18 new Smart App customers supporting more than 450 insurers. The AI-enabled tools target underwriting, claims, broking, distribution and operations, letting insurers start with a single business priority and scale capabilities over time.

Nearly Half of US Shoppers Now Buy Luxury Goods Secondhand, Study Finds

Image
Nearly Half of US Shoppers Now Buy Luxury Goods Secondhand, Study Finds

Brooklyn, N.Y. – – October 08, 2026 -- Secondhand shopping in the United States has expanded far beyond thrift-store apparel, with 76% of Americans buying used goods in the past 12 months and 89% having done so at some point, according to a new report from The Consumer Collective.

Luxury resale emerges as the fastest-growing category among younger buyers

The firm's "Second Nature: The State of Secondhand Shopping in America" report found 49% of consumers already buy luxury items secondhand or would consider it, a figure that climbs to nearly 80% once undecided shoppers are included. Gen Z (61%) and Millennials (60%) lead this trend, more than double the 27% rate among consumers aged 62 and older. Condition and authenticity remain the top barriers cited by shoppers hesitant to buy used luxury goods.

VA Taps CLEAR's Biometric ID Platform to Fight $186B Payment Fraud

Image
VA Taps CLEAR's Biometric ID Platform to Fight $186B Payment Fraud

New York – – October 08, 2026 -- The U.S. Department of Veterans Affairs has integrated CLEAR's secure identity platform, CLEAR1, into a pilot program designed to simplify account access for the nation's roughly 17 million living Veterans while combating fraud across federal benefit programs.

VA.gov sign-in now offers biometric verification via selfie

Veterans can now create or access their VA.gov account using CLEAR1, which combines biometrics, government-issued identification and trusted data sources to verify identity. After a one-time setup, future sign-ins require only a selfie, reducing reliance on traditional usernames and passwords. VA operates the largest integrated health care system in the country, serving 9.1 million enrolled Veterans annually, and VA.gov serves as the primary digital gateway to earned benefits and services.

Elsevier Adds 13 JAMA Journals to ClinicalKey AI Platform

Image
Elsevier Adds 13 JAMA Journals to ClinicalKey AI Platform

New York – October 08, 2026 -- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI, its clinical-grade AI workspace, giving clinicians access to more than half of the world's top 100 medical journals through the platform.

Agreement covers 13 JAMA Network titles including flagship journal and specialty publications

The deal brings all published full-text content and visuals from JAMA, JAMA Network Open, and 11 specialty journals -- JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery -- into the responses clinicians receive through ClinicalKey AI. Content is available to ClinicalKey AI customers immediately.

IMM, Nuravax Dose First Patients in World's First Active Tau Vaccine Trial

Image
IMM, Nuravax Dose First Patients in World's First Active Tau Vaccine Trial

Orange County, Calif. – October 08, 2026 -- The Institute for Molecular Medicine (IMM) and Nuravax have dosed the first four participants in TAURUS-1980, a Phase 1 trial testing AV-1980R, described as the world's first active immunotherapy targeting pathological tau protein linked to Alzheimer's disease.

Trial targets at-risk adults before cognitive symptoms appear

TAURUS-1980 will enroll up to 48 cognitively unimpaired adults aged 65 to 80 who have biomarker-confirmed brain amyloid pathology, a known precursor to Alzheimer's. Participants are randomized 3:1 to receive AV-1980R or placebo across three ascending-dose cohorts of 20, 60, and 180 micrograms.

Lakewood-Amedex's Nu-8 Cuts E. coli Growth by 97% in UTI Model

Image
Lakewood-Amedex's Nu-8 Cuts E. coli Growth by 97% in UTI Model

Sarasota, Fla. – October 08, 2026 -- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) reported that its Bisphosphocin compound Nu-8, delivered intravesically to rodents infected with E. coli, achieved up to 97% inhibition of bacterial growth using a 10% solution, against no effect in a vehicle control group.

Nu-8 targets drug-resistant bacteria linked to catheter-associated UTIs

The Bisphosphocin class has shown in vitro activity against a broad range of resistant bacteria common in urinary tract infections, including E. coli, K. pneumoniae, and P. aeruginosa, and against biofilm-forming organisms. Complicated UTIs, particularly catheter-associated urinary tract infections, are frequently driven by drug-resistant strains and biofilm formation, a persistent challenge for hospital infection control.

Simple Mining Buys Sphere 3D's 8 MW Iowa Site, Nears 160 MW

Image
Simple Mining Buys Sphere 3D's 8 MW Iowa Site, Nears 160 MW

Cedar Falls, Iowa – October 08, 2026 -- Simple Mining has acquired an approximately 8 MW Bitcoin mining facility in Iowa from Sphere 3D Corp. (NASDAQ: ANY), pushing its total Iowa hosting platform to nearly 160 MW.

Acquired site adds 2,200 miners to Simple Mining's owned infrastructure

The facility supports roughly 2,200 latest-generation miners and expands the owned hosting capacity available to Simple Mining's customers, who purchase and host machines on the company's infrastructure. The site joins Simple Mining's existing network of Iowa facilities and will operate under the same in-house model covering machine sales, hosting, and repair.

X-Bow Wins Nearly $70M Navy Deal for Next-Gen Missile Booster

Image
X-Bow Wins Nearly $70M Navy Deal for Next-Gen Missile Booster

Albuquerque, N.M. – October 08, 2026 -- X-Bow Systems has secured a prototype agreement worth up to $69.7 million to develop and qualify a solid rocket motor booster for a U.S. Navy next-generation weapon program targeting surface warfare threats.

Pentagon funds phased development with $50 million obligated upfront

The agreement, administered by U.S. Army Contracting Command – Rock Island, splits into a $50.4 million Phase 1 development effort and a $19.3 million Phase 2 qualification option. Of the total, $50 million has been obligated at award to fund a 12-month Phase 1 timeline.

Navy targets early FY 2031 fielding of common interceptor architecture

The program replaces single-purpose interceptors with a shared architecture, including variants designed to pack more interceptors into each launch system. The Navy expects an initial operational capability in early FY 2031.